SHANGHAI, China, Aug. 29, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the United States Food and Drug Administration (the “FDA”), alongside the Office of the Assistant Secretary for Preparedness and Response, has resumed the […]
TO: ALL PERSONS WHO OWN SHARES OF STATE STREET CORPORATION COMMON STOCK AS OF JUNE 24, 2021 (“SHAREHOLDERS”): BOSTON, Aug. 27, 2021 (GLOBE NEWSWIRE) — Please read this notice carefully and in its entirety. Your rights may be affected by the proceedings described in this notice. A proposed settlement has been reached in this action, […]
Nyxoah Appoints Rita Johnson-Mills to its Board of Directors Mont-Saint-Guibert, Belgium – August 27, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that it has appointed […]
For the third consecutive year, the Gartner report recognizes Epicor for its vision and execution Austin, Texas, Aug. 27, 2021 (GLOBE NEWSWIRE) — Epicor Software Corporation, a global provider of industry-specific enterprise software to promote business growth, has been named a Visionary in the 2021 Gartner Magic Quadrant for Cloud ERP for Product-Centric Enterprisesi for the third consecutive […]
ImmunoBrain Checkpoint Awarded $5 Million US NIA Grant for Phase 1b Alzheimer’s Disease Proof-of-Mechanism Study of Anti-PD-L1 IBC-Ab002 NEW YORK, Friday August 27, 2021 – ImmunoBrain Checkpoint Inc. (“IBC”) an innovative biopharmaceutical company developing potential disease-modifying immune therapies that harness the power of the immune system to help protect and repair the brain to combat […]
SHANGHAI, China, Aug. 27, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (NMPA) of China has accepted an investigational new drug application for UBP1213sc, its subcutaneous injection of recombinant humanized […]
First closing of dedicated Canadian fund provides investing capacity of more than CAD$550 million for investments in senior living, student housing, medical office, life sciences, storage, and digital assets CHICAGO and TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) — Harrison Street, one of the leading investment management firms exclusively focused on alternative real assets, today announced […]
